Ratan HL - Search Results

1

Resveratrol--a prostate cancer chemopreventive agent?

Ratan HL, Steward WP, Gescher AJ, Mellon JK. Ratan HL, et al. Urol Oncol. 2002 Nov-Dec;7(6):223-7. doi: 10.1016/s1078-1439(02)00194-1. Urol Oncol. 2002. PMID: 12504842 Review.

2

ErbB receptors: possible therapeutic targets in prostate cancer?

Ratan HL, Gescher A, Steward WP, Mellon JK. Ratan HL, et al. BJU Int. 2003 Dec;92(9):890-5. doi: 10.1111/j.1464-410x.2003.04503.x. BJU Int. 2003. PMID: 14632841 Review. No abstract available.

3

Mammalian target of rapamycin: a new target in prostate cancer.

Rai JS, Henley MJ, Ratan HL. Rai JS, et al. Among authors: ratan hl. Urol Oncol. 2010 Mar-Apr;28(2):134-8. doi: 10.1016/j.urolonc.2009.03.023. Epub 2009 Jun 12. Urol Oncol. 2010. PMID: 19523861 Review.

4

Contemporary practice and technique-related outcomes for radical prostatectomy in the UK: a report of national outcomes.

Laird A, Fowler S, Good DW, Stewart GD, Srinivasan V, Cahill D, Brewster SF, McNeill SA; British Association of Urological Surgeons (BAUS). Laird A, et al. BJU Int. 2015 May;115(5):753-63. doi: 10.1111/bju.12866. Epub 2014 Oct 22. BJU Int. 2015. PMID: 25046349

5

MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.

Jackson BL, Grabowska A, Ratan HL. Jackson BL, et al. Among authors: ratan hl. BMC Cancer. 2014 Dec 10;14:930. doi: 10.1186/1471-2407-14-930. BMC Cancer. 2014. PMID: 25496077 Free PMC article. Review.

6

Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic.

Gao C, Peters M, Kurver P, Anbarasan T, Jayaraajan K, Manning T, Cashman S, Nambiar A, Cumberbatch M, Lamb BW, Pickard R, Erotocritou P, Smith D, Kasivisvanathan V, Shah TT; BURST Collaborative MIMIC Study Group. Gao C, et al. BJU Int. 2022 Jun 28;130(6):823-31. doi: 10.1111/bju.15839. Online ahead of print. BJU Int. 2022. PMID: 35762278 Free PMC article.

7

KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach.

Green WJ, Ball G, Hulman G, Johnson C, Van Schalwyk G, Ratan HL, Soria D, Garibaldi JM, Parkinson R, Hulman J, Rees R, Powe DG. Green WJ, et al. Among authors: ratan hl. Br J Cancer. 2016 Jul 12;115(2):236-42. doi: 10.1038/bjc.2016.169. Epub 2016 Jun 23. Br J Cancer. 2016. PMID: 27336609 Free PMC article.

8

Update on the management of T1 renal cortical tumours.

Cutress ML, Ratan HL, Williams ST, O'Brien MF. Cutress ML, et al. Among authors: ratan hl. BJU Int. 2010 Oct;106(8):1130-6. doi: 10.1111/j.1464-410X.2010.09506.x. Epub 2010 Aug 25. BJU Int. 2010. PMID: 20738293 Review.

9

Potential use of RNA interference as therapeutic strategy in urologic cancer.

Green WJ, James PA, Ratan HL. Green WJ, et al. Among authors: ratan hl. Urology. 2011 Sep;78(3):500-4. doi: 10.1016/j.urology.2011.04.036. Epub 2011 Jul 13. Urology. 2011. PMID: 21741681 No abstract available.

10

3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase Inhibitors.

Onion D, Argent RH, Reece-Smith AM, Craze ML, Pineda RG, Clarke PA, Ratan HL, Parsons SL, Lobo DN, Duffy JP, Atherton JC, McKenzie AJ, Kumari R, King P, Hall BM, Grabowska AM. Onion D, et al. Among authors: ratan hl. Mol Cancer Ther. 2016 Apr;15(4):753-63. doi: 10.1158/1535-7163.MCT-15-0598. Epub 2016 Feb 12. Mol Cancer Ther. 2016. PMID: 26873730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page